M
$ Value
$1.3M
Shares
11,521
Price
$116
Filed
Sep 3
Insider
Name
Forminard Elizabeth
Title
Executive VP, General Counsel
CIK
0001950802
Roles
Officer
Transaction Details
Transaction Date
2025-08-29
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
22,423
Footnotes
Vested and exercisable on the third anniversary of the date of the grant.
Filing Info
Forminard Elizabeth's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-15 | JNJ | M | $0 |
| 2026-02-15 | JNJ | F | $120K |
| 2026-02-15 | JNJ | M | $0 |
| 2026-02-15 | JNJ | F | $132K |
| 2026-02-15 | JNJ | M | $0 |
| 2026-02-15 | JNJ | M | $0 |
| 2026-02-15 | JNJ | A | $0 |
| 2026-02-15 | JNJ | A | $0 |
| 2026-02-13 | JNJ | M | $0 |
| 2026-02-13 | JNJ | F | $77K |
Other Insiders at JNJ (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
REED JOHN C
EVP, Innovative Medicine, R&D
|
— | $13.1M | 2026-02-17 |
|
Duato Joaquin
CEO and Chairman of the Board
|
— | $22.1M | 2026-02-15 |
|
Wolk Joseph J
Exec VP, CFO
|
— | $21.8M | 2026-02-17 |
|
Taubert Jennifer L
EVP, WWC. Innovative Medicine
|
— | — | 2026-02-15 |
|
Wengel Kathryn E
EVP, Chief TO and Risk Officer
|
— | — | 2026-02-15 |
|
Decker Robert J
VP Corporate Controller
|
— | — | 2026-02-15 |
|
Swanson James D.
EVP, CIO
|
— | $15.1M | 2026-02-17 |
|
Broadhurst Vanessa
EVP, Global Corp Affairs
|
— | $1.5M | 2026-02-17 |
|
Forminard Elizabeth
EVP, Chief Legal Officer
|
— | — | 2026-02-15 |
|
Schmid Timothy
EVP, WW Chair, MedTech
|
— | $5.5M | 2026-02-18 |
|
Mulholland Kristen
EVP, Chief HR Officer
|
— | — | 2026-02-15 |